Furthermore, the American Cancer Society, the American College of Radiology, and the Society of Breast Imaging recommend annual screening by breast magnetic resonance imaging as an intensified screening for breast cancer, especially for patients treated at an age <30 years, similar to the already established screening for high-risk patients with a BRCA1 mutation (42, 43). This evidence concerns the gene BRCA1 and breast cancer.